Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Hypokalemia | Case report

Caffeine-induced hypokalemia: a case report

Authors: Min Jee Han, Su-Hyun Kim, Jung-ho Shin, Jin Ho Hwang

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

With an increase in the global popularity of coffee, caffeine is one of the most consumed ingredients of modern times. However, the consumption of massive amounts of caffeine can lead to severe hypokalemia.

Case presentation

A 29-year-old man without a specific past medical history was admitted to our hospital with recurrent episodes of sudden and severe lower-extremity weakness. Laboratory tests revealed low serum potassium concentration (2.6–2.9 mmol/L) and low urine osmolality (100–130 mOsm/kgH2O) in three such prior episodes. Urinary potassium/urinary creatinine ratio was 12 and 16 mmol/gCr, respectively. The patient was not under medication with laxatives, diuretics, or herbal remedies. Through an in-depth interview, we found that the patient consumed large amounts of caffeine-containing beverages daily, which included > 15 cups of coffee, soda, and various kinds of tea. After the cessation of coffee intake and concomitant intravenous potassium replacement, the symptoms rapidly resolved, and the serum potassium level normalized.

Conclusions

An increased intracellular shift of potassium and increased loss of potassium in urine due to the diuretic action have been suggested to be the causes of caffeine-induced hypokalemia. In cases of recurring hypokalemia of unknown cause, high caffeine intake should be considered.
Literature
1.
go back to reference Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U. S. Food Chem Toxicol. 2014;63:136–42. Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U. S. Food Chem Toxicol. 2014;63:136–42.
2.
go back to reference Alazami M, Lin SH, Cheng CJ, Davids MR, Halperin ML. Unusual causes of hypokalaemia and paralysis. QJM: monthly journal of the Association of Physicians. 2006;99(3):181–92.CrossRef Alazami M, Lin SH, Cheng CJ, Davids MR, Halperin ML. Unusual causes of hypokalaemia and paralysis. QJM: monthly journal of the Association of Physicians. 2006;99(3):181–92.CrossRef
3.
go back to reference Aizaki T, Osaka M, Hara H, Kurokawa S, Matsuyama K, Aoyama N, Soma K, Ohwada T, Izumi T. Hypokalemia with syncope caused by habitual drinking of oolong tea. Internal medicine. 1999;38(3):252–6.CrossRef Aizaki T, Osaka M, Hara H, Kurokawa S, Matsuyama K, Aoyama N, Soma K, Ohwada T, Izumi T. Hypokalemia with syncope caused by habitual drinking of oolong tea. Internal medicine. 1999;38(3):252–6.CrossRef
4.
go back to reference Abbott PJ. Caffeine: a toxicological overview. The Medical journal of Australia. 1986;145(10):518–21.CrossRef Abbott PJ. Caffeine: a toxicological overview. The Medical journal of Australia. 1986;145(10):518–21.CrossRef
5.
go back to reference Appel CC, Myles TD. Caffeine-induced hypokalemic paralysis in pregnancy. Obstetrics gynecology. 2001;97(5 Pt 2):805–7.PubMed Appel CC, Myles TD. Caffeine-induced hypokalemic paralysis in pregnancy. Obstetrics gynecology. 2001;97(5 Pt 2):805–7.PubMed
6.
go back to reference Kamijo Y, Takai M, Fujita Y, Usui K. A Retrospective Study on the Epidemiological and Clinical Features of Emergency Patients with Large or Massive Consumption of Caffeinated Supplements or Energy Drinks in Japan. Internal medicine. 2018;57(15):2141–6.CrossRef Kamijo Y, Takai M, Fujita Y, Usui K. A Retrospective Study on the Epidemiological and Clinical Features of Emergency Patients with Large or Massive Consumption of Caffeinated Supplements or Energy Drinks in Japan. Internal medicine. 2018;57(15):2141–6.CrossRef
7.
go back to reference Tsuji T, Morita S, Saito T, Nakagawa Y, Inokuchi S. Serum potassium level as a biomarker for acute caffeine poisoning. Acute Med Surg. 2020;7(1):e568.CrossRef Tsuji T, Morita S, Saito T, Nakagawa Y, Inokuchi S. Serum potassium level as a biomarker for acute caffeine poisoning. Acute Med Surg. 2020;7(1):e568.CrossRef
8.
go back to reference Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. The Safety of Ingested Caffeine: A Comprehensive Review. Front Psychiatry. 2017;8:80.CrossRef Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. The Safety of Ingested Caffeine: A Comprehensive Review. Front Psychiatry. 2017;8:80.CrossRef
9.
go back to reference Gilbert RM, Marshman JA, Schwieder M, Berg R. Caffeine content of beverages as consumed. Canadian Medical Association journal. 1976;114(3):205–8.PubMedPubMedCentral Gilbert RM, Marshman JA, Schwieder M, Berg R. Caffeine content of beverages as consumed. Canadian Medical Association journal. 1976;114(3):205–8.PubMedPubMedCentral
10.
go back to reference The European Food Safety Authority Panel on Dietetic Products NaA. Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;15(5):120. The European Food Safety Authority Panel on Dietetic Products NaA. Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;15(5):120.
11.
go back to reference Willson C. The clinical toxicology of caffeine: A review and case study. Toxicol Rep. 2018;5:1140–52.CrossRef Willson C. The clinical toxicology of caffeine: A review and case study. Toxicol Rep. 2018;5:1140–52.CrossRef
13.
go back to reference Packer CD. Chronic hypokalemia due to excessive cola consumption: a case report. Cases J. 2008;1(1):32.CrossRef Packer CD. Chronic hypokalemia due to excessive cola consumption: a case report. Cases J. 2008;1(1):32.CrossRef
14.
go back to reference Passmore AP, Kondowe GB, Johnston GD. Caffeine and hypokalemia. Ann Intern Med. 1986;105(3):468.CrossRef Passmore AP, Kondowe GB, Johnston GD. Caffeine and hypokalemia. Ann Intern Med. 1986;105(3):468.CrossRef
15.
go back to reference Tajima Y. Coffee-induced Hypokalaemia. Clin Med Insights Case Rep. 2010;3:9–13.CrossRef Tajima Y. Coffee-induced Hypokalaemia. Clin Med Insights Case Rep. 2010;3:9–13.CrossRef
16.
go back to reference Benowitz NL. Clinical pharmacology of caffeine. Annual review of medicine 1990, 41:277–288. Benowitz NL. Clinical pharmacology of caffeine. Annual review of medicine 1990, 41:277–288.
17.
go back to reference Arnaud MJ. The pharmacology of caffeine. Progress in drug research Fortschritte der Arzneimittelforschung Progres des recherches pharmaceutiques. 1987;31:273–313.PubMed Arnaud MJ. The pharmacology of caffeine. Progress in drug research Fortschritte der Arzneimittelforschung Progres des recherches pharmaceutiques. 1987;31:273–313.PubMed
18.
go back to reference Bradberry SM, Vale JA. Disturbances of potassium homeostasis in poisoning. J Toxicol Clin Toxicol. 1995;33(4):295–310.CrossRef Bradberry SM, Vale JA. Disturbances of potassium homeostasis in poisoning. J Toxicol Clin Toxicol. 1995;33(4):295–310.CrossRef
19.
go back to reference Mao X, Chai Y, Lin YF. Dual regulation of the ATP-sensitive potassium channel by caffeine. Am J Physiol Cell Physiol. 2007;292(6):C2239–58.CrossRef Mao X, Chai Y, Lin YF. Dual regulation of the ATP-sensitive potassium channel by caffeine. Am J Physiol Cell Physiol. 2007;292(6):C2239–58.CrossRef
20.
go back to reference Chorvatova A, Hussain M. Effects of caffeine on potassium currents in isolated rat ventricular myocytes. Pflugers Arch. 2003;446(4):422–8.CrossRef Chorvatova A, Hussain M. Effects of caffeine on potassium currents in isolated rat ventricular myocytes. Pflugers Arch. 2003;446(4):422–8.CrossRef
21.
go back to reference Varro A, Hester S, Papp JG. Caffeine-induced decreases in the inward rectifier potassium and the inward calcium currents in rat ventricular myocytes. Br J Pharmacol. 1993;109(4):895–7.CrossRef Varro A, Hester S, Papp JG. Caffeine-induced decreases in the inward rectifier potassium and the inward calcium currents in rat ventricular myocytes. Br J Pharmacol. 1993;109(4):895–7.CrossRef
22.
go back to reference Palatini P, Canali C, Graniero GR, Rossi G, de Toni R, Santonastaso M, dal Follo M, Zanata G, Ferrarese E, Mormino P, et al. Relationship of plasma renin activity with caffeine intake and physical training in mild hypertensive men. HARVEST Study Group. Eur J Epidemiol. 1996;12(5):485–91.CrossRef Palatini P, Canali C, Graniero GR, Rossi G, de Toni R, Santonastaso M, dal Follo M, Zanata G, Ferrarese E, Mormino P, et al. Relationship of plasma renin activity with caffeine intake and physical training in mild hypertensive men. HARVEST Study Group. Eur J Epidemiol. 1996;12(5):485–91.CrossRef
23.
go back to reference Himathongkam T, Dluhy RG, Williams GH. Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab. 1975;41(1):153–9.CrossRef Himathongkam T, Dluhy RG, Williams GH. Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab. 1975;41(1):153–9.CrossRef
24.
go back to reference Rieg T, Vallon V, Sausbier M, Sausbier U, Kaissling B, Ruth P, Osswald H. The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion. Kidney Int. 2007;72(5):566–73.CrossRef Rieg T, Vallon V, Sausbier M, Sausbier U, Kaissling B, Ruth P, Osswald H. The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion. Kidney Int. 2007;72(5):566–73.CrossRef
25.
go back to reference Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases. 2014;2(10):488–96.CrossRef Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases. 2014;2(10):488–96.CrossRef
26.
go back to reference Eriksson JW, Jansson PA, Carlberg B, Hagg A, Kurland L, Svensson MK, Ahlstrom H, Strom C, Lonn L, Ojbrandt K, et al. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. Hypertension. 2008;52(6):1030–7.CrossRef Eriksson JW, Jansson PA, Carlberg B, Hagg A, Kurland L, Svensson MK, Ahlstrom H, Strom C, Lonn L, Ojbrandt K, et al. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. Hypertension. 2008;52(6):1030–7.CrossRef
27.
go back to reference Tourniaire J, Bajard L, Harfouch M, Rebattu B, Garrel D. Restoration of insulin sensitivity after correction of hypokalemia due to chronic tubulopathy in a diabetic patient. Diabete Metab. 1988;14(6):717–20.PubMed Tourniaire J, Bajard L, Harfouch M, Rebattu B, Garrel D. Restoration of insulin sensitivity after correction of hypokalemia due to chronic tubulopathy in a diabetic patient. Diabete Metab. 1988;14(6):717–20.PubMed
28.
go back to reference Amlal H, Krane CM, Chen Q, Soleimani M. Early polyuria and urinary concentrating defect in potassium deprivation. Am J Physiol Renal Physiol. 2000;279(4):F655–63.CrossRef Amlal H, Krane CM, Chen Q, Soleimani M. Early polyuria and urinary concentrating defect in potassium deprivation. Am J Physiol Renal Physiol. 2000;279(4):F655–63.CrossRef
Metadata
Title
Caffeine-induced hypokalemia: a case report
Authors
Min Jee Han
Su-Hyun Kim
Jung-ho Shin
Jin Ho Hwang
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Hypokalemia
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02465-0

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.